Phase II clinical trial of OKT3 for acute graft-versus-host disease (GVHD) prophylaxis in allogeneic bone marrow transplantation (alloBMT).

被引:0
|
作者
Alam, A [1 ]
Baer, MR [1 ]
Bernstein, S [1 ]
Bernstein, Z [1 ]
Christiansen, N [1 ]
Czuczman, M [1 ]
Schriber, J [1 ]
Slack, J [1 ]
Tezcan, H [1 ]
Wetzler, M [1 ]
Cooper, M [1 ]
Milk, B [1 ]
Ford, L [1 ]
Herzig, G [1 ]
McCarthy, P [1 ]
机构
[1] ROSWELL PK CANC INST,BUFFALO,NY
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:449 / 449
页数:1
相关论文
共 50 条
  • [1] Analysis of OKT3 for acute graft-versus-host disease (GVHD) prophylaxis in allogeneic bone marrow transplant (BMT) patients.
    McCarthy, P
    Hahn, T
    Cooper, M
    Brady, A
    Miller, A
    Baer, M
    Bambach, B
    Bernstein, S
    Bernstein, Z
    Czuczman, M
    Slack, J
    Wetzler, M
    Herzig, G
    Stewart, C
    BLOOD, 2000, 96 (11) : 341B - 341B
  • [2] Muromonab-CD3 (Orthoclone OKT3®), methylprednisolone and cyclosporine for acute graft-versus-host disease prophylaxis in allogeneic bone marrow transplantation
    Benekli, M.
    Hahn, T.
    Williams, B. T.
    Cooper, M.
    Roy, H. N.
    Wallace, P.
    Stewart, C.
    Bambach, B.
    McCarthy, P. L., Jr.
    BONE MARROW TRANSPLANTATION, 2006, 38 (05) : 365 - 370
  • [3] Muromonab-CD3 (Orthoclone OKT3®), methylprednisolone and cyclosporine for acute graft-versus-host disease prophylaxis in allogeneic bone marrow transplantation
    M Benekli
    T Hahn
    B T Williams
    M Cooper
    H N Roy
    P Wallace
    C Stewart
    B Bambach
    P L McCarthy
    Bone Marrow Transplantation, 2006, 38 : 365 - 370
  • [4] Prophylaxis of acute hepatic graft-versus-host disease with ursodeoxycholic acid in allogeneic bone marrow transplantation
    Iwata, N
    Nakamura, Y
    Masui, H
    Seto, Y
    Takemoto, Y
    Kakishita, E
    HEPATOLOGY, 1997, 26 (04) : 1091 - 1091
  • [5] GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS WITH ANTI-T-CELL MONOCLONAL-ANTIBODY OKT3, PREDNISONE AND METHOTREXATE IN ALLOGENEIC BONE-MARROW TRANSPLANTATION
    FILIPOVICH, AH
    KRAWCZAK, CL
    KERSEY, JH
    MCGLAVE, P
    RAMSAY, NKC
    BRITISH JOURNAL OF HAEMATOLOGY, 1985, 60 (01) : 143 - 152
  • [6] PHARMACOLOGICAL PROPHYLAXIS OF ACUTE GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC MARROW TRANSPLANTATION
    SCHWINGHAMMER, TL
    BLOOM, EJ
    CLINICAL PHARMACY, 1993, 12 (10): : 736 - 761
  • [7] ACUTE GRAFT-VERSUS-HOST DISEASE IN ALLOGENEIC MARROW TRANSPLANTATION
    PARKER, N
    COHEN, T
    NURSING CLINICS OF NORTH AMERICA, 1983, 18 (03) : 569 - 577
  • [8] Acute Graft-Versus-Host Disease of the Kidney in Allogeneic Rat Bone Marrow Transplantation
    Higo, Seiichiro
    Shimizu, Akira
    Masuda, Yukinari
    Nagasaka, Shinya
    Kajimoto, Yusuke
    Kanzaki, Go
    Fukui, Megumi
    Nagahama, Kiyotaka
    Mii, Akiko
    Kaneko, Tomohiro
    Tsuruoka, Shuichi
    PLOS ONE, 2014, 9 (12):
  • [9] ACUTE GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
    PERREAULT, C
    GYGER, M
    BOILEAU, J
    BONNY, Y
    COUSINEAU, S
    LACOMBE, M
    LAVALLEE, R
    TAWIL, E
    DANGELO, G
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 1983, 129 (09) : 969 - 974
  • [10] Bone marrow transplantation and approaches to avoid graft-versus-host disease (GVHD)
    Blazar, BR
    Murphy, WJ
    PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 2005, 360 (1461) : 1747 - 1767